One big problem with existing cancer therapies available today like chemotherapy and radiation is the collateral damage. While some medicine… Read More
Seattle biotechnology startup Blaze Bioscience has raised $8.5 million to continue developing technologies that are designed to help surgeons more… Read More
Seattle-based biotech upstart Kineta announced a new investment partnership with RLB Holdings, a Connecticut-based investment firm that partially owns the… Read More
Resolve Therapeutics, a 2-year-old Seattle biotechnology spin off from the University of Washington, has raised $5.8 million in new financing… Read More
TaxACT co-founder Lance Dunn has been appointed to the board of Blucora, the search and tax preparation company formerly known as InfoSpace. Blucora purchased TaxACT… Read More
Another day, another executive departure from RealNetworks. Yesterday, we reported that chief financial officer Michael Eggers — a 14-year veteran… Read More
Theraclone Sciences, a Seattle biotechnology company that’s developing a method to rapidly identify disease-fighting antivbodies, has attracted $10.6 million. Investors… Read More
